In addition, APG-1387 could induce tumor cell death and enhance innate antitumor immunity in HBV-positive hepatocellular carcinoma with a high expression of cIAP2 and stimulate adaptive immunity in vitro by reducing Treg differentiation and PD-1 expression [158]. Here, PDCD1 is linked to neoplasm.